NO20032913D0 - Neurotrofiske tacrolimusanaloger - Google Patents
Neurotrofiske tacrolimusanalogerInfo
- Publication number
- NO20032913D0 NO20032913D0 NO20032913A NO20032913A NO20032913D0 NO 20032913 D0 NO20032913 D0 NO 20032913D0 NO 20032913 A NO20032913 A NO 20032913A NO 20032913 A NO20032913 A NO 20032913A NO 20032913 D0 NO20032913 D0 NO 20032913D0
- Authority
- NO
- Norway
- Prior art keywords
- neurotrophic
- tacrolimus
- analogues
- tacrolimus analogues
- neurotrophic tacrolimus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Packages (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25850000P | 2000-12-29 | 2000-12-29 | |
| PCT/US2001/050419 WO2002053159A1 (en) | 2000-12-29 | 2001-12-31 | Neurotrophic tacrolimus analogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20032913D0 true NO20032913D0 (no) | 2003-06-24 |
Family
ID=22980816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20032913A NO20032913D0 (no) | 2000-12-29 | 2003-06-24 | Neurotrofiske tacrolimusanaloger |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1353671A4 (no) |
| JP (1) | JP2004527472A (no) |
| KR (2) | KR20070030331A (no) |
| CN (1) | CN1293877C (no) |
| AR (1) | AR035411A1 (no) |
| AU (1) | AU2002231277B2 (no) |
| BR (1) | BR0116762A (no) |
| CA (1) | CA2433384A1 (no) |
| CZ (1) | CZ20032060A3 (no) |
| HU (1) | HUP0302521A3 (no) |
| IL (1) | IL156664A0 (no) |
| MX (1) | MXPA03005941A (no) |
| NO (1) | NO20032913D0 (no) |
| NZ (1) | NZ527209A (no) |
| PL (1) | PL366301A1 (no) |
| RU (1) | RU2288716C2 (no) |
| WO (1) | WO2002053159A1 (no) |
| ZA (1) | ZA200305806B (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003901023A0 (en) * | 2003-03-04 | 2003-03-20 | Fujisawa Pharmaceutical Co., Ltd. | New use |
| JP2007518692A (ja) * | 2004-01-20 | 2007-07-12 | アステラス製薬株式会社 | 勃起不全治療方法 |
| EP1810675A1 (en) * | 2006-01-18 | 2007-07-25 | Institut Curie | Method for treating Huntington's disease by inhibiting dephosphorylation of huntingtin at S421 |
| JP2009102226A (ja) * | 2006-02-14 | 2009-05-14 | Meiji Milk Prod Co Ltd | 脊髄損傷治療剤 |
| US9149459B2 (en) | 2008-07-23 | 2015-10-06 | Novartis Ag | Sphingosine 1 phosphate receptor modulators and their use to treat muscle inflammation |
| JP2015511242A (ja) * | 2012-02-23 | 2015-04-16 | インセルム（インスティチュート ナショナル デ ラ サンテ エ デ ラリシェルシェ メディカル） | 病変性前庭障害の治療に使用するカルシニューリン阻害剤 |
| GB201309375D0 (en) * | 2013-05-24 | 2013-07-10 | Chronos Therapeutics Ltd | Medical methods and compounds for medical use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0346427B1 (en) * | 1987-12-09 | 1995-03-29 | FISONS plc | Macrocyclic compounds |
| GR1001225B (el) * | 1989-09-14 | 1993-06-30 | Fisons Plc | Νέαι μακροκυκλικαί ενώσεις και νέα μέ?οδος χρήσεως τους. |
| US5541193A (en) * | 1991-09-05 | 1996-07-30 | Abbott Laboratories | Heterocycle-containing macrocyclic immunomodulators |
| GB9202196D0 (en) * | 1992-02-01 | 1992-03-18 | Fisons Plc | Method of treatment |
| GB9218027D0 (en) * | 1992-08-25 | 1992-10-14 | Fisons Plc | Novel method of treatment |
| GB9917158D0 (en) * | 1999-07-21 | 1999-09-22 | Fujisawa Pharmaceutical Co | New use |
-
2001
- 2001-12-27 AR ARP010106058A patent/AR035411A1/es unknown
- 2001-12-31 AU AU2002231277A patent/AU2002231277B2/en not_active Ceased
- 2001-12-31 CA CA002433384A patent/CA2433384A1/en not_active Abandoned
- 2001-12-31 NZ NZ527209A patent/NZ527209A/en unknown
- 2001-12-31 CN CNB018228860A patent/CN1293877C/zh not_active Expired - Fee Related
- 2001-12-31 PL PL01366301A patent/PL366301A1/xx not_active Application Discontinuation
- 2001-12-31 KR KR1020077003889A patent/KR20070030331A/ko not_active Application Discontinuation
- 2001-12-31 JP JP2002554109A patent/JP2004527472A/ja not_active Ceased
- 2001-12-31 KR KR1020037008787A patent/KR100794204B1/ko not_active IP Right Cessation
- 2001-12-31 BR BR0116762-6A patent/BR0116762A/pt not_active Application Discontinuation
- 2001-12-31 CZ CZ20032060A patent/CZ20032060A3/cs unknown
- 2001-12-31 IL IL15666401A patent/IL156664A0/xx unknown
- 2001-12-31 RU RU2003123493/15A patent/RU2288716C2/ru not_active IP Right Cessation
- 2001-12-31 EP EP01991558A patent/EP1353671A4/en not_active Withdrawn
- 2001-12-31 WO PCT/US2001/050419 patent/WO2002053159A1/en active IP Right Grant
- 2001-12-31 MX MXPA03005941A patent/MXPA03005941A/es active IP Right Grant
- 2001-12-31 HU HU0302521A patent/HUP0302521A3/hu unknown
-
2003
- 2003-06-24 NO NO20032913A patent/NO20032913D0/no not_active Application Discontinuation
- 2003-07-28 ZA ZA2003/05806A patent/ZA200305806B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2433384A1 (en) | 2002-07-11 |
| EP1353671A4 (en) | 2004-07-14 |
| AU2002231277B2 (en) | 2006-11-30 |
| KR20070030331A (ko) | 2007-03-15 |
| BR0116762A (pt) | 2004-08-10 |
| KR20040007431A (ko) | 2004-01-24 |
| CN1293877C (zh) | 2007-01-10 |
| KR100794204B1 (ko) | 2008-01-14 |
| WO2002053159A1 (en) | 2002-07-11 |
| IL156664A0 (en) | 2004-01-04 |
| HUP0302521A3 (en) | 2007-03-28 |
| RU2288716C2 (ru) | 2006-12-10 |
| AR035411A1 (es) | 2004-05-26 |
| PL366301A1 (en) | 2005-01-24 |
| EP1353671A1 (en) | 2003-10-22 |
| CN1538843A (zh) | 2004-10-20 |
| RU2003123493A (ru) | 2005-01-20 |
| NZ527209A (en) | 2005-09-30 |
| JP2004527472A (ja) | 2004-09-09 |
| HUP0302521A2 (hu) | 2003-11-28 |
| MXPA03005941A (es) | 2005-02-14 |
| ZA200305806B (en) | 2005-01-26 |
| CZ20032060A3 (cs) | 2004-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2012018I2 (el) | Αναλογα σωματοστατινης | |
| DE60108147D1 (de) | Temperaturmessballon | |
| NO20032101D0 (no) | Apoliprotein analoger | |
| DE60117334D1 (de) | Gassack | |
| DE60126694D1 (de) | Beatmungsgerät | |
| ATA16182001A (de) | Einbau-wölb-verwind-stütze | |
| DE60132401D1 (de) | Tiefpassfilter | |
| DE60107598D1 (de) | Smart-skin strukturen | |
| FI20000854A (fi) | Adsorbenttikatalyytti | |
| DE60206321D1 (de) | Aufblasvorrichtung | |
| DE60203590D1 (de) | Aufblasvorrichtung | |
| DE60113294D1 (de) | Aufblasvorrichtung | |
| DE60212579D1 (de) | Aufblasvorrichtung | |
| DE60226891D1 (de) | Aufblasvorrichtung | |
| NO20032913D0 (no) | Neurotrofiske tacrolimusanaloger | |
| DE60233830D1 (de) | Haltekonsolen-Struktur | |
| FI20010718A0 (fi) | Ilmapallon kiinnitin | |
| DE60134285D1 (de) | Förderer | |
| DE50105875D1 (de) | Bauteil | |
| DE60205683D1 (de) | Aufblasvorrichtung | |
| DE50111882D1 (de) | Verdeck | |
| DE50105097D1 (de) | Beatmungsgerät | |
| FR2813906B1 (fr) | Plancher technique | |
| ATA12432000A (de) | Bauelement | |
| DE60136565D1 (de) | Aufblasvorrichtung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CREP | Change of representative |
Representative=s name: PLOUGMANN 6 VINGTOFT POSTBOKS 1003 SENTRUM OSLO, 0 |
|
| CREP | Change of representative |
Representative=s name: ZACCO NORWAY AS POSTBOKS 2003 VIKA OSLO, 0125 NO |
|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |